Stolte M, Meining A
Department of Pathology, Klinikum Bayreuth, Germany.
J Gastroenterol. 2000;35 Suppl 12:98-101.
Several studies have shown that Helicobacter pylori infection implies an increased risk for developing gastric carcinoma. However, it has to be considered that only a few among those infected with H. pylori develop gastric cancer. It is therefore desirable to identify risk indicators of H. pylori gastritis in the presence of which gastric carcinoma is most likely to occur. In our view, the risk indicators intestinal metaplasia and atrophy, frequently cited in the literature, are not suitable, as they are focal changes whose detection at the routine diagnostic workup may be confounded by sampling error and because early carcinoma (in particular of the diffuse type) is often not associated with intestinal metaplasia or atrophy. For this reason we investigated the diffuse gastritis parameters "grade of gastritis" and "activity of gastritis" for their suitability as risk indicators. We found that H. pylori gastritis, particularly in the corpus, is significantly more pronounced in gastric carcinoma patients or individuals with a family history of gastric cancer than in matched controls. Hence, a simple comparison of the grade of gastritis and activity of gastritis in the antrum and corpus might help identify patients with H. pylori gastritis with an increased cancer risk. Currently. we are testing this hypothesis in an ongoing gastric cancer prevention study in Germany, Austria, and Czechia.
多项研究表明,幽门螺杆菌感染会增加患胃癌的风险。然而,必须考虑到,在感染幽门螺杆菌的人群中,只有少数人会患上胃癌。因此,有必要确定幽门螺杆菌胃炎的风险指标,在这些指标存在的情况下,最有可能发生胃癌。我们认为,文献中经常提到的风险指标肠化生和萎缩并不合适,因为它们是局灶性变化,在常规诊断检查中其检测可能会因抽样误差而混淆,而且早期癌(特别是弥漫型)通常与肠化生或萎缩无关。因此,我们研究了弥漫性胃炎参数“胃炎分级”和“胃炎活动度”作为风险指标的适用性。我们发现,幽门螺杆菌胃炎,尤其是胃体部的幽门螺杆菌胃炎,在胃癌患者或有胃癌家族史的个体中比在匹配的对照组中明显更严重。因此,简单比较胃窦和胃体部的胃炎分级和胃炎活动度可能有助于识别幽门螺杆菌胃炎且患癌风险增加的患者。目前,我们正在德国、奥地利和捷克进行的一项胃癌预防研究中检验这一假设。